Posted by: admin on: December 6, 2011
Obesity is a major cause of worry in developed and developing countries and a drain to the health care system. New York’s compulsory calorie label law, on the fast foods has made a difference. Read on to see how. Team@CMHF
Posted by: admin on: December 6, 2011
A selective estrogen receptor modulator (SERM) bazedoxifene is on the trial, to be approved as a drug for prevention of postmenopausal osteoporosis. Here is an article showing the clinical efficacy and safety of bazedoxifene in the treatment of postmenopausal osteoporosis. Team@CMHF
Posted by: admin on: December 6, 2011
The new calcium channel blocker azelnidipine found to have an added effect on Olmesartan action on hypertensive diabetic patients, has an advantage in chronic kidney patients. Here is the study. Team@CMHF